Clostridium innocuum: Microbiological and clinical characteristics of a potential emerging pathogen
Abstract
No abstract availableKeywords
Funding Information
- Crohn's and Colitis Foundation of America
- National Center for Advancing Translational Sciences (UL1TR001422)
- National Institutes of Health (R21 AI144549, T32 916225)
- National Institute of Allergy and Infectious Diseases
This publication has 32 references indexed in Scilit:
- Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infectionBMC Infectious Diseases, 2010
- Clostridium innocuum Bacteremia in a Patient With Acquired Immunodeficiency SyndromeThe American Journal of the Medical Sciences, 2009
- Infection after Elective Colorectal Surgery: Bacteriological Analysis of Failures in a Randomized Trial of Cefotetan vs. Ertapenem ProphylaxisSurgical Infections, 2009
- Epidemiology and Outcomes of Clostridial Bacteremia at a Tertiary-Care InstitutionThe Scientific World Journal, 2009
- Clostridium bacteraemia characterised by 16S ribosomal RNA gene sequencingJournal of Clinical Pathology, 2005
- Mechanism of Intrinsic Resistance to Vancomycin in Clostridium innocuum NCIB 10674Journal of Bacteriology, 2004
- Clostridium innocuum EndocarditisClinical Infectious Diseases, 1995
- Clostridial infection in childrenJournal of Medical Microbiology, 1995
- How Far Should a Clinical Laboratory Go in Identifying Anaerobic Isolates, and Who Should Pay?Clinical Infectious Diseases, 1993
- Isolation of Clostridium in Human Infections: Evaluation of 114 CasesThe Journal of Infectious Diseases, 1975